Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
980 results
D1.62 - Improved In-vitro Allergy Diagnostics using a Molecular Composite of Purified Peanut Allergens
D1.63 - Descriptive Study on the Evolution of Patients Treated with Oral Immunotherapy (OIT) Using Pasteurized Egg White at the Fundación Alcorcón University Hospital
D1.64 - Severe Food Protein-Induced Enterocolitis Syndrome: A French Multicenter Study of Children Admitted to Critical Care
D1.65 - Pollen Food Allergy Syndrome in Patients with Quercus ilex Sensitization in the Population of Madrid
D1.66 - Reactivity, severity and tolerance development in 50 wheat-allergic children across two oral food challenges
D1.67 - Development and validation of Skin Prick Test solutions for assessing sensitization patterns to edible insects among children sensitized to house dust mite
D1.69 - Safety in the peach juice food challenge in LTP allergic patients
D1.70 - No more restrictive diets for LTP allergic patients. The importance of oral food challenge
D1.71 - Risk Factors for Anaphylaxis in Food-Allergic Children During Oral Food Challenge Tests
D1.72 - Comparison of the allergenic composition of available SPTs for the diagnosis of sensitization to D. pteronyssinus
D1.88 - Mepolizumab and intestinal parasitic infection: A case report
D1.91 - Baseline characteristics and main clinical outcomes of patients receiving tezepelumab in the framework of use in Special Situations prior to commercialization in Spain (T-ROSS Study)
D1.92 - Results from the EGPAware Delphi study on Red Flags for Suspicion of Eosinophilic Granulomatosis with Polyangiitis (EGPA): current management in Europe
D1.93 - ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up
D1.94 - Impact of overweight and obesity on clinical remission and Response to Biologics in Severe Asthma Patients
D1.95 - Dupilumab-induced eosinophilia: a transient effect
D1.96 - Impact of Dupilumab-induced Eosinophilia on Pulmonary Function Tests and Patient Reported Outcomes Measures (PROMs)
D1.99 - Exploring the relationship between 6 minutes walk test (6MWT) performance and lung function in Severe Asthma and CRSwNP
D2.102 - Adult Gut Microbiota and Metabolomics in Different Phenotypes of Asthma
D2.103 - Exploring association between lung function, asthma and epigenetic predisposition to obesity
Pagination
First page
First
Previous page
Previous
…
Page
33
Page
34
Page
35
Page
36
Current page
37
Page
38
Page
39
Page
40
Page
41
…
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download